Quarterly report pursuant to Section 13 or 15(d)

Acquisition (Details)

v2.4.0.8
Acquisition (Details) (USD $)
9 Months Ended
Sep. 30, 2014
Aug. 21, 2014
Aug. 13, 2014
sample
Dec. 31, 2013
Business Acquisition [Line Items]        
Significant Acquisitions and Disposals, Assets Acquired, Samples     5,000  
Payments to Acquire Intangible Assets $ 8,000,000      
Other Commitment 500,000      
Significant Acquisitions and Disposals, Acquisition Costs or Sale Proceeds   500,000    
Payments to Acquire Businesses, Net of Cash Acquired 8,000,000      
Other Accrued Liabilities 500,000     0
Business Combination, Contingent Consideration, Liability 4,476,000      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities 12,976,000 100,000    
Finite-Lived Intangible Assets, Gross 12,976,000      
Diagnostic Assets [Domain]
       
Business Acquisition [Line Items]        
Finite-Lived Intangible Asset, Useful Life 7 years 10 months 24 days      
Finite-Lived Intangible Assets, Gross 12,976,000      
Diagnostic Lab [Member]
       
Business Acquisition [Line Items]        
Finite-Lived Intangible Asset, Useful Life 2 years 3 months      
Finite-Lived Intangible Assets, Gross $ 609,000      
Diagnostic Test - Pancreas [Member]
       
Business Acquisition [Line Items]        
Royalty Percentage 5.00%      
Diagnostic Test - Thyroid [Member]
       
Business Acquisition [Line Items]        
Royalty Percentage 3.50%      
Diagnostic Test - Other Thyroid [Member]
       
Business Acquisition [Line Items]        
Royalty Percentage 1.50%